Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Xenon Pharmaceuticals Inc. (XENE)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 64.6 | 69.5 | 57.2 | 103.5 | 370.0 | 116.5 | 175.7 | 87.8 |
| Short-term investments | | | | | 418.3 | 421.4 | | 161.8 |
| Accounts receivable, net | 2.1 | 2.2 | 1.0 | 2.5 | 2.5 | 2.9 | 2.8 | 3.2 |
| Other current assets | 477.9 | 461.6 | 542.1 | 543.2 | 4.0 | 4.8 | 380.6 | 3.5 |
| Total current assets | 544.6 | 533.4 | 600.3 | 649.2 | 794.8 | 545.6 | 559.0 | 256.3 |
| Property, plant, and equipment, net | 9.6 | 8.0 | 6.5 | 4.6 | 4.5 | 4.3 | 4.5 | 4.3 |
| Total assets | 684.9 | 719.9 | 754.1 | 775.8 | 807.4 | 558.1 | 572.0 | 264.4 |
| |
| Accounts payable | 12.0 | 11.4 | 8.5 | 3.1 | 3.2 | 1.7 | 3.8 | 3.1 |
| Accrued expenses | 5.8 | 3.5 | 6.2 | 5.2 | 4.3 | 2.3 | 6.2 | 3.8 |
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other current liabilities | 10.3 | 7.6 | 8.0 | 7.3 | 6.3 | 4.1 | 4.3 | 6.0 |
| Total current liabilities | 28.2 | 22.5 | 22.7 | 15.5 | 13.7 | 8.0 | 14.3 | 12.9 |
| Other liabilities | 10.3 | 10.4 | 9.9 | 7.2 | 7.9 | 8.2 | 7.7 | 2.6 |
| Total liabilities | 38.4 | 32.9 | 32.6 | 22.7 | 21.6 | 16.2 | 22.0 | 15.4 |
| |
| Shareholders' equity [+] | 646.5 | 686.9 | 721.5 | 753.1 | 785.8 | 541.9 | 550.0 | 248.9 |
| Paid-in capital | 138.7 | 140.1 | 142.1 | 136.7 | 133.3 | 119.6 | 117.5 | 69.6 |
| Retained earnings | -571.9 | -524.5 | -482.7 | -445.4 | -408.2 | -377.0 | -357.4 | -331.8 |
| Tangible shareholders' equity | 646.5 | 686.9 | 721.5 | 753.1 | 785.8 | 541.9 | 550.0 | 248.9 |
|